Related Experiment Video
Updated: May 30, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Gerstmann-Sträussler-Scheinker syndrome masquerading as multiple sclerosis
Yuval Karmon1, Arielle Kurzweil, Eric Lindzen
1Baird MS Center, Jacobs Neurological Institute SUNY Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203, United States. yuvalk1@hotmail.com
Gerstmann-Sträussler-Scheinker syndrome (GSS), a rare inherited prion disease, can mimic other neurological disorders due to its varied presentation. This case highlights GSS
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- Gerstmann-Sträussler-Scheinker syndrome (GSS) is a rare, inherited human prion disease characterized by neurodegeneration.
- It typically follows an autosomal dominant inheritance pattern and exhibits significant genetic and phenotypic heterogeneity.
- GSS is known for its prolonged clinical course, often mimicking other neurological conditions.
Observation:
- A patient presented with a progressive ataxic syndrome.
- Initial magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) findings suggested a demyelinating-inflammatory process, such as multiple sclerosis.
- Subtle diagnostic clues eventually led to the identification of GSS.
Findings:
- The case illustrates the diagnostic challenges posed by GSS, particularly when its symptoms overlap with other neurological disorders.
- Advanced diagnostic techniques and careful clinical correlation were crucial in differentiating GSS from initial misdiagnoses.
- This underscores the importance of considering rare prion diseases in the differential diagnosis of progressive neurological syndromes.
Implications:
- Accurate and timely diagnosis of GSS is essential for patient management and genetic counseling.
- Understanding the phenotypic variability of GSS can improve diagnostic accuracy in clinical practice.
- Further research into GSS pathogenesis may reveal novel therapeutic targets for prion diseases.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Esophageal Achalasia
Schizophrenia

